Skip to content

Side by side

Cardiogen vs CJC-1295

Both are discussed for anti-aging & longevity. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.

Cardiogen and CJC-1295 compared on what BioAlmanac records.
 CardiogenCJC-1295
What it isAssigned to cardiac tissue by the St Petersburg programme that invented this category. Four decades of Russian work sit behind it, and none of it has been reproduced anywhere else.A GHRH analogue that raises growth hormone by amplifying the body's own release signal. Sold in two forms whose durations differ by two orders of magnitude.
EvidenceHow much human evidence exists, not how well it works.PreclinicalEarly human trials
Regulatory statusReviewed 2026-08-18Not approved for human use in the United States, the European Union or the United Kingdom. Some peptides in this family are registered in Russia as supplements or medicines. Cardiogen is sold elsewhere as a research chemical.Not approved for human use in the United States. The FDA has identified CJC-1295 as a substance raising concerns for use in compounded preparations. Sold only as a research chemical.
RoutesSubcutaneous, OralSubcutaneous
Half-lifeNot recorded0.5 hours
Cheapest per mgVials only, read from vendors' own listings and dated on the price index.$1.79/mg$2.40/mg
Median per mg$3.00/mg$7.25/mg
Vendors with a price1240
Storage once mixedRefrigerated at 2–8 °C. Do not freeze once mixed.Refrigerated at 2–8 °C. Do not freeze once mixed.

Compare two other compounds · The full price index

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.